v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 12,533 $ 19,655
Short-term investments 84,248 94,942
Accounts receivable, net 32,429 25,622
Insurance recovery receivable related to legal loss (Note 8) 8,191 8,039
Prepaid expenses and other current assets 5,132 4,736
Total current assets 142,533 152,994
Property and equipment, net 9,415 7,583
Operating lease right-of-use assets 4,337 6,121
Other intangible assets, net 70 206
Goodwill 5,898 5,898
Other assets 1,148 837
Total assets 163,401 173,639
Current liabilities:    
Accounts payable 3,410 3,888
Accrued expenses 6,575 6,533
Accrued legal loss (Note 8) 11,500 11,500
Accrued salary and benefits 11,362 10,457
Deferred revenue 4,613 5,382
Operating leases 2,796 2,624
Finance leases 45 44
Total current liabilities 40,301 40,428
Operating leases, non-current 2,112 4,231
Finance leases, non-current 39 72
Other liabilities 987 801
Total liabilities 43,439 45,532
Commitments and contingencies (Note 8)
Stockholders’ equity    
Preferred stock $0.005 par value, 100,000 shares authorized and no shares issued and outstanding as of September 30, 2026 and December 31, 2025 0 0
Common stock $0.005 par value, 1,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 65,676 and 63,264 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 329 317
Additional paid-in capital 484,796 469,560
Accumulated other comprehensive (loss) income (58) 32
Accumulated deficit (365,105) (341,802)
Total stockholders’ equity 119,962 128,107
Total liabilities and stockholders’ equity $ 163,401 $ 173,639